Takehiko Naka
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Pharmacology top 10%
- Co-authors
- Keiji KuboYasuhisa KoharaTakeo WadaKohei NishikawaYoshiyuki InadaEiko ImamiyaYoshiyasu FurukawaSidney M. Hecht
- Topics
- Synthesis and Characterization of Heterocyclic Compounds (9 papers)Synthesis and biological activity (8 papers)Synthesis and Biological Evaluation (7 papers)
- Cited by
- Organic ChemistryCardiology and Cardiovascular MedicineEndocrinology, Diabetes and Metabolism
- Partner nations
- JapanUnited States
In The Last Decade
Takehiko Naka
37 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 733
- Organic Chemistry 621
- Cardiology and Cardiovascular Medicine 411
- Endocrinology, Diabetes and Metabolism 229
- Pharmacology 104
Countries citing papers authored by Takehiko Naka
This map shows the geographic impact of Takehiko Naka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiko Naka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiko Naka more than expected).
Fields of papers citing papers by Takehiko Naka
This network shows the impact of papers produced by Takehiko Naka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiko Naka. The network helps show where Takehiko Naka may publish in the future.
Co-authorship network of co-authors of Takehiko Naka
This figure shows the co-authorship network connecting the top 25 collaborators of Takehiko Naka. A scholar is included among the top collaborators of Takehiko Naka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiko Naka. Takehiko Naka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 30 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 43 | |
| 7 | 19 | |
| 8 | Angiotensin II receptor antagonistic action of candesartan (CV-11974) in the rabbit aorta | 2 |
| 9 | 33 | |
| 10 | 41 | |
| 11 | Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116. | 14 |
| 12 | 4 | |
| 13 | 111 | |
| 14 | 200 | |
| 15 | 117 | |
| 16 | 115 | |
| 17 | 7 | |
| 18 | 3 | |
| 19 | 77 | |
| 20 | 4 |
About Takehiko Naka
Takehiko Naka is a scholar working on Organic Chemistry, Endocrinology, Diabetes and Metabolism and Hematology, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (9 papers), Synthesis and biological activity (8 papers) and Synthesis and Biological Evaluation (7 papers). The work is most often cited by research in Organic Chemistry (621 citations), Cardiology and Cardiovascular Medicine (411 citations) and Endocrinology, Diabetes and Metabolism (229 citations). Takehiko Naka has collaborated with scholars based in Japan and United States. Frequent co-authors include Keiji Kubo, Yasuhisa Kohara, Takeo Wada, Kohei Nishikawa, Yoshiyuki Inada, Eiko Imamiya, Yoshiyasu Furukawa, Sidney M. Hecht, Yumiko Shibouta and Yasuhiro Inada. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.